The management of asthma has evolved significantly over the past decade, with advancements in diagnosis, treatment, and patient education. This article provides a comprehensive update on these advancements, aiming to equip healthcare professionals with the latest knowledge in asthma management.
Recent years have seen considerable improvements in asthma diagnosis. High-resolution computed tomography (HRCT) and impulse oscillometry (IOS) are now commonly used to identify airway remodeling and assess lung function. Moreover, the use of biomarkers such as fractional exhaled nitric oxide (FeNO) and eosinophil count in sputum is becoming increasingly prevalent, providing more accurate and personalized diagnosis.
Therapeutic advancements have led to the development of novel drugs such as biologics and bronchial thermoplasty. Biologics, including mepolizumab and reslizumab, target specific immune pathways, reducing exacerbations and improving lung function. Bronchial thermoplasty, a non-pharmacological intervention, reduces smooth muscle mass in the airways, thus decreasing the severity of asthma attacks.
Effective asthma management relies heavily on patient education. Digital health technologies, such as smartphone apps and telemedicine, have revolutionized patient education. These technologies enable real-time monitoring of symptoms, medication adherence, and provide personalized advice, leading to improved patient outcomes.
Advancements in asthma management have revolutionized the approach towards this chronic disease. The integration of advanced diagnostic tools, novel therapeutic interventions, and digital health technologies has significantly improved patient outcomes. As healthcare professionals, it is crucial to stay updated with these advancements to provide the best possible care to our patients.
1.
Does Maintenance Therapy Extend Life in mCRC?
2.
What does it mean for Biden's prostate cancer to be 'aggressive'? A urologic surgeon explains
3.
Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement
4.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
5.
Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients
1.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
2.
Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers
3.
Personalized Survivorship Navigation in Precision Cancer Care
4.
Hematopoietic Stem Cell Exhaustion in Blood Disorders
5.
Hematopoietic Clonal Competition in Blood Disorders
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Advances in Modern Cancer Treatment
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
4.
Early Warning Signs of Cancer
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation